1. Home
  2. PTPI

as 12-20-2024 4:00pm EST

$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.

;SMA (50)$0.32EMA (200)$0.64O: $0.30 H: $0.32 L: $0.25 C: $0.29 −0.01 (−3.48%)Elder Ray −0.03, −0.10
Founded: 2020 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 3.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 4.4M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.26 EPS Growth: N/A
52 Week Low/High: $0.22 - $2.27 Next Earning Date: 11-13-2024
Revenue: $4,022,389 Revenue Growth: -42.41%
Revenue Growth (this year): -4.8% Revenue Growth (next year): 0.76%

PTPI Daily Stock ML Predictions

SELLHOLDBUYas of 2 days ago

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use